 |
 |
Redefining Care for Hormone Receptor-Positive Metastatic Breast Cancer
How to Navigate Critical Decision Points |
|
| CPD |
|
|
VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA
BARCELONA, SPAIN
MONDAY, 16 SEPTEMBER, 2024 | 18:30 - 20:00 CEST |
|
| LEARN MORE |
|
Led by a panel of leading experts, this interactive educational program will delve into the ever-changing landscape of hormone receptor (HR)-positive metastatic breast cancer (MBC). Participants will learn how to apply the latest approaches in patient care to their own clinical practice, through deepening their understanding of available molecular targets and their expanding list of targeted therapies.
Novel ways of targeting the estrogen receptor and the PI3K/AKT/mTOR signaling axis will be discussed, followed by a comprehensive tour of targeting HR-positive disease with antibody-drug conjugates (ADCs). Experts will then take turns in the “hot seat” to answer your queries on the use of ADCs in HR-positive MBC, before providing their personal highlights of the Barcelona meeting at its conclusion – one not to miss!
Live polling questions and an interactive audience Q&A session will round off this unique learning opportunity, designed to enhance learners' practice knowledge, competence, and confidence.
This CPD symposium will be offered both in person and virtually. Please note: you will need to be a registered attendee of ESMO 2024 in order to participate. |
|
| LEARN MORE |
|
|
|
|
|
|
|
|
| FACULTY |
|
| Javier Cortés, MD, PhD |
|
| MODERATOR |
|
| Head, International Breast Cancer Center, IBCC, Barcelona; Head, IOB Madrid, Institute of Oncology, Madrid, Spain |
|
|
|
| Aditya Bardia, MD, MPH, FASCO |
|
| PANELIST |
|
| Professor of Medicine, Director, Breast Oncology Program, Assistant Chief (Translational Research), Division of Medical Oncology, Director of Translational Research Integration, UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, California, United States |
|
|
|
| Sibylle Loibl, MD, PhD |
|
| PANELIST |
|
| Chair, German Breast Group, Professor, Goethe University Frankfurt, Clinical Consultant, Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany |
|
|
|
| Paolo Tarantino, MD |
|
| PANELIST |
|
| Advanced Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States |
|
|
|
|
|
|
|
| |
|
